Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
HTX DAO Launches $HTX Holding-Based Voting Mechanism, Ushering in a New Era of Decentralized Governance
-
Form 8.5 (EPT/RI) - Serinus Energy Plc
-
GeeMee Attended Game Developers Conference (GDC) 2025 in San Francisco, Highlighted Insights on Mobile Gaming Trends
-
Form 8.5 (EPT/RI) - LondonMetric Property Plc
-
Form 8.3 - AXA INVESTMENT MANAGERS: Aviva plc
-
Form 8.5 (EPT/RI) - Advanced Medical Solutions Group plc
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
FUN Token unveils 2025 roadmap to transform gaming into a rewarding digital economy
-
Form 8.5 (EPT/RI) - De La Rue plc
-
Form 8.5 (EPT/RI) - Alliance Pharma plc
-
Aiden Labs Launches $ADN Token, Revolutionizing AI-Powered Web3 Experiences
-
Form 8.5 (EPT/RI) - Thruvision Group plc
-
$731 Billion In Home Equity Expected To Be Locked-In Due To "Negative Credit Shocks" Homeowners Will Face This Year
-
$731 Billion In Home Equity Expected To Be Locked-In Due To "Negative Credit Shocks" Homeowners Will Face This Year
-
Ebenbuild Contributes Cutting-Edge Digital Lung Simulations to Pulmonary Fibrosis Drug Development
-
ENA Respiratory Partners with University of Maryland and Leading Respiratory Disease Expert to Conduct Phase 2 Study of INNA-051 Antiviral Host Defence Enhancer
-
Toobit Wins Best Crypto Exchange MENA 2025 at World Business Outlook Awards
-
XRP Bulls Rush to BlocScale Launchpad, as $BLOC Token Seed Sale Becomes the Hottest Opportunity on XRP Ledger
-
Major shareholder announcement – Danske Bank A/S
-
SBC Medical to Present at the Emerging Growth Conference on April 17, 2025
-
Net Asset Value(s)
-
West Red Lake Gold Reflects on Madsen Mine Achievements To Date
-
Nokia, Telia and Finnish Defense Forces achieve world’s first 5G standalone slice handover across borders
-
ValoTx Appoints Marcella Origgi from Johnson & Johnson Innovation as CEO
-
Tive Launches Solo Pro: All-In-One, Real-Time Visibility Solution to Accelerate Pharmaceutical Product Releases
-
ValoTx Appoints Marcella Origgi from Johnson & Johnson Innovation as CEO
-
Orrön Energy publishes it’s Annual and Sustainability Report for 2024
-
Vaisala's Interim Report January–March 2025 to be published on April 24, 2025
-
Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer
-
Invitation to HMS Networks’ first quarter conference call 2025
-
FIJI Water Joins the Fashion Trust U.S. Awards Through Exclusive Partnership and Designer Collaboration
-
Trifork subsidiary Nine wins strategically important contract for the Danish Agency for Digital Government: Developing Denmark’s Digital Identity Wallet
-
Bang & Olufsen interim report for 9M 2024/25: Bang & Olufsen reports a Q3 with topline growth, margin improvement and profit
-
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress
-
Management Increasing Ownership in Amaroq Minerals and RSU Vesting Update
-
RIBER reports solid growth in sales and earnings in 2024
-
Aegon announces reset of perpetual subordinated bonds
-
Transaction in Own Shares
-
SBM Offshore signs US$400 million Sale and Leaseback agreement for FPSO Cidade de Paraty
-
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025
-
DEME signs agreement to acquire Norwegian offshore wind infrastructure company Havfram
-
Start of Day Message
-
The effect of aprocitentan for reducing blood pressure and proteinuria in Black patients with resistant hypertension published in Hypertension
-
Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors
-
VGP announces nomination of Mr. Chris Morrish as member of its Board of Directors
-
Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2
-
Convocation to the Annual Shareholders’ Meeting and the Special Shareholders’ Meeting of 9 May 2025
-
AMG Approves US Chrome Manufacturing Plant
-
US FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirement
-
Stallion Uranium Increases Private Placement to $1.45 Million

